(Q80457727)
Statements
Recombinant growth hormone use pretransplant and risk for post-transplant lymphoproliferative disease--a report of the NAPRTCS (English)
Vikas R Dharnidharka
Lynya I Talley
Karen L Martz
Donald M Stablein
21 December 2007